DXCM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
CEO
Kevin Sayer
Employees
5500
Headquarters

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com

News

Here’s What Happened to Dexcom (DXCM) Stock in Q4
Mar 27, 2024 11:02am

Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returns of 14.08% in the quarter slightly lagged the 14.55% return for the Russell Midcap Growth Index. The fund declined 27.14% for […]


Source:Insider Monkey
Citi maintains Buy rating on DexCom with $148 target
Mar 25, 2024 18:07pm

https://www.investing.com/news/stock-market-news/citi-maintains-buy-rating-on-dexcom-with-148-target-93CH-3352064


Source:Investing.com
What''s Driving DexCom Inc''s Surprising 14% Stock Rally?
Mar 25, 2024 16:17pm

What''s Driving DexCom Inc''s Surprising 14% Stock Rally?


Source:GuruFocus
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed''s Powell A Tailwind
Mar 23, 2024 12:00pm

S&P 500 stocks DexCom, Blackstone and Royal Caribbean lead five stocks around buy points after Fed chief Jerome Powell helped buoy markets.


Source:Investor''s Business Daily
DexCom Stock Trying To Close In On Key Technical Benchmark
Mar 18, 2024 18:47pm

DexCom shows rising price performance, earning an upgrade to its IBD Relative Strength Rating


Source:Investor''s Business Daily
3 Stocks That Could Benefit from the Rise of Telemedicine
Mar 14, 2024 16:44pm

With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That’s according to Emergen Research. By 2034, it could hit $888.1 billion , says Prophecy Market Insights. All creating big opportunities for telemedicine stocks. First made popular during the pandemic, it’s become a much-needed fixture for a lot of patients who just don’t want to drive to the doctor or sit in the waiting room. Unless there’s a medical emergency that requires a doctor visit, patients can get prescriptions, treatment recommendations or even have their vitals checked with connected medical devices. Telehealth platforms are even great for visits with mental health professionals. For example, according to mHealth Intelligence , “Digital mental health visits are also among trends in telemedicine as they rank highest among the specialties in 2023. According to statistics, by the third quarter of 2023, 37% of mental health visits took place virtually, followed by infectious disease, obstetrics and transplant.” While I personally like to visit my doctor for a more thorough examination, millions of people are opting for telehealth care.


Source:InvestorPlace
IBD Stock Of The Day Dexcom Lingers In Buy Zone As Diabetes Play Eyes Obesity Market
Mar 13, 2024 16:04pm

Dexcom is Wednesday''s IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor.


Source:Investor''s Business Daily
DexCom started at outperform at RBC on diabetes total addressable market
Mar 12, 2024 16:52pm

No summary available.


Source:Seeking Alpha
What''s Driving DexCom Inc''s Surprising 13% Stock Rally?
Mar 07, 2024 14:12pm

What''s Driving DexCom Inc''s Surprising 13% Stock Rally?


Source:GuruFocus
Jefferies bullsih on DexCom, highlights Stelo drug hype
Mar 07, 2024 13:40pm

https://www.investing.com/news/stock-market-news/jefferies-bullsih-on-dexcom-highlights-stelo-drug-hype-93CH-3328789


Source:Investing.com